Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical TrialEstebán Martínez, Sergio Padilla, Elena Ferrer et al.|Clinical Infectious Diseases|2014Cited by 29
Effectiveness and tolerability of abacavir‐lamivudine‐nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV‐infected, ARV‐naïve patientsDaniel Podzamczer, Nerea Rozas, Josep M. Llibre et al.|Journal of the International AIDS Society|2014Cited by 2